Strides Arcolab Inks Deal With U.S. Firm
Strides Arcolab Ltd. said on Wednesday it had struck a five-year contract with
a U.S.-based firm to develop four injectable products for the United States
market in a deal valued at $90-160 million. Shares of the Bangalore-based company
rose as much as 8 per cent to a high of 202.5 rupees at the Bombay Stock Exchange
whose benchmark index was flat.
The Economic Times